Enanta Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell

Enanta Pharmaceuticals, Inc. (Nasdaq: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, visits the Nasdaq MarketSite in Times Square to celebrate its 10-year anniversary of its Initial Public Offering. In honor of the occasion, Jay R. Luly, Ph.D., President, Chief Executive Officer and Director, rings the Closing Bell.